FMP
VanEck Pharmaceutical ETF
PPH
NASDAQ
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
86.92 USD
1 (1.15%)
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
NASDAQ
Description
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
CIK
0001137360
ISIN
US92189F6925
CUSIP
92189F692
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Feb 1, 2000
Key Executives
